Purespring Therapeutics
Description: Purespring Therapeutics pioneers AAV gene therapy targeting podocytes to treat kidney diseases, backed by £45M from Syncona Ltd.
Country: UK
Based in: London
Founded: 2020
Funding Stage: Seed
Tags: ['Biotechnology', 'Medical Device', 'Diagnostics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
